| Name: | Acalabrutinib Impurity 11 |
| Catalogue No. | VE007042 |
| CAS No. | 2490433-97-9 |
| Molecular Formula | C30H25N7O3 |
| Molecular Weight | 531.6 g/mol |
| Status | In-Stock |
| IUPAC Name | (S)-4-(9-(1-(but-2-ynoyl)pyrrolidin-2-yl)-4-methyl-2-oxo-2H-imidazo[5',1':3,4]pyrazino[1,2-a]pyrimidin-11-yl)-N-(pyridin-2-yl)benzamide |
| Description | Acalabrutinib Impurity 11 (cas no.-2490433-97-9) IUPAC Name-(S)-4-(9-(1-(but-2-ynoyl)pyrrolidin-2-yl)-4-methyl-2-oxo-2H-imidazo[5',1':3,4]pyrazino[1,2-a]pyrimidin-11-yl)-N-(pyridin-2-yl)benzamide. Its an impurity of acalabrtinib. Acalabrutinib is a selective irreversible second-generation BTK inhibitor used against solid tumours. |
| References | Wu, Jingjing, et al. “Acalabrutinib (ACP-196): A Selective Second-Generation BTK Inhibitor.” Journal of Hematology & Oncology, vol. 9, no. 1, Mar. 2016, https://doi.org/10.1186/s13045-016-0250-9. |
